Astrazeneca Plc

LONDON, January 28 - Pharmaceutical group AstraZeneca announced it's Q4 and full-year results today with CEO David Brennan saying in a video interview on www.cantos.com that cost control and restructuring had helped deliver a revenue line above company expectations.